SCHEMBL6162728

SCHEMBL6162728

NC(=O)c1cnc(NC(=O)[CH]Cc2ccccc2)s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNE1 P24864 9/20 0.50
CDK2 P24941 9/20 0.50
CDK5 Q00535 8/20 0.50
GSTO1 P78417 1/20 0.43
CCNE2 O96020 1/20 0.43
FFAR2 O15552 1/20 0.42
MAPK13 O15264 1/20 0.42
MAPK12 P53778 1/20 0.42
MAPK11 Q15759 1/20 0.42
MAPK14 Q16539 1/20 0.42
ALDH1A1 P00352 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
MEN1 O00255 1/20 0.41
ABL1 P00519 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
NFKB1 P19838 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL893108 0.75 NPC1 (0.50) CCNE1CDK2CDK5MAPK13MAPK12
SCHEMBL31707000 0.70 NPC1 (0.66) FFAR2ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL21533551 0.70 ALDH1A1 (0.60) ALDH1A1LMNAMAPK1
SCHEMBL4067815 0.69 TGM2 (0.55) ALDH1A1SMN1; SMN2MEN1TP53MAPT
SCHEMBL6165136 0.68 PKM (0.41) ALDH1A1SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL4025365 0.68 ATM (0.45) ALDH1A1SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL3345536 0.68 HTT (0.41) ALDH1A1NPC1RAB9ALMNAHPGD
SCHEMBL2021250 0.67 CCNE1 (0.76) CCNE1CDK2CDK5ALDH1A1SMN1; SMN2
SCHEMBL14887666 0.67 FFAR2 (0.46) FFAR2MAPK13MAPK12MAPK11MAPK14
SCHEMBL892779 0.67 MAPT (0.68) CCNE1CDK2CDK5ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1134213-B1 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER (US) 2005-11-02 EP disclosed
EP-0832065-B1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER (US) 2001-10-10 EP disclosed
EP-1134213-A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER INC. (US) 2001-09-19 EP disclosed
US-6277877-B1 GLYCOGEN PHOSPHORYLASE INHIBITOR; ANTIDIABETIC AGENTS PFIZER, INC. 2001-08-21 US disclosed
US-6107329-A HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS PFIZER, INC. (US) 2000-08-22 US disclosed
WO-1996039384-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER, INC. (US) 1996-12-12 WO disclosed